Parabilis Medicines (PBLS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 28 100 sessions, June 10, 2026 to October 30, 2026
- Largest daily move
- -12.7% close of September 23, 2026
- 1-month change
- -12.3% closing prices, September 30, 2026 to October 30, 2026
Company Description
Parabilis Medicines (NASDAQ: PBLS) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $3.6B.
PBLS has declined 12.3% over the past month. The last closing price was $28.32.
This page collects what Stock Titan holds for PBLS, including price data, latest news, SEC filings, upcoming events, and short interest trends.
Stock Performance
Parabilis Medicines (PBLS) closed at $28.32 on October 30, 2026. Over the past month, the price has lost 12.3%.
PBLS Metrics & Rankings
Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Parabilis Medicines has 8 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, management, earnings, IPO, offering. View all PBLS news →
SEC Filings
Parabilis Medicines has filed 10 recent SEC filings, including 4 Form 8-K, 2 Form 4, 2 Form SCHEDULE 13G, 1 Form 3. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PBLS SEC filings →
Financial Highlights
Upcoming Events
FAP data readout
PEDESTAL Phase 3 start
PEDESTAL topline results
Parabilis Medicines has 3 upcoming scheduled events. The next event, "FAP data readout", is expected in Q1 2027. Investors can track these dates to stay informed about potential catalysts that may affect the PBLS stock price.
Short Interest History
Short interest in Parabilis Medicines (PBLS) currently stands at 9.3 million shares, up 12.0% from the previous reporting period, representing 8.8% of the float. Since June 2026, short interest has increased by 728.5%.
Days to Cover History
Days to cover for Parabilis Medicines (PBLS) currently stands at 9.5 days, up 96.3% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since June 2026, the figure has increased by 614.3%. Across the settlements charted above, it has ranged from 1.3 to 15.7 days.
PBLS Company Profile & Sector Positioning
Parabilis Medicines (PBLS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing PBLS often look at related companies in the same sector, including Xenon Pharmaceuticals Inc (XENE), Disc Medicine, Inc. (IRON), Acadia Pharmaceuticals Inc. (ACAD), Tarsus Pharmaceuticals, Inc. (TARS), and Viking Therapeutics, Inc (VKTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PBLS's relative position within its industry.